A plant compound called Broussoflavonol F reduced obesity and improved metabolic health in mice by restoring healthy gut bacteria, according to a 2026 research study. After six weeks of treatment, obese mice lost significant weight, reduced body fat, lowered cholesterol levels, and improved blood sugar control. Gram Research analysis shows the compound worked by increasing beneficial bacteria like Lactobacillus and reducing the bacterial imbalance associated with obesity, though human studies are needed to confirm these effects in people.
Researchers discovered that a natural plant compound called Broussoflavonol F (BPF) may help fight obesity by repairing the gut bacteria of overweight mice. When obese mice ate this compound for six weeks, they lost weight, had lower cholesterol, and their gut bacteria became healthier and more diverse. The study shows that the compound works by changing which bacteria live in the gut, increasing good bacteria like Lactobacillus while reducing harmful ones. This research suggests that fixing gut bacteria imbalance could be a new way to treat obesity, though human studies are still needed to confirm these findings.
Key Statistics
A 2026 research study in mice found that Broussoflavonol F treatment for six weeks significantly reduced body weight, adipose tissue mass, and serum lipid levels (total cholesterol, triglycerides, and LDL cholesterol) in obese mice fed a high-fat diet.
According to research reviewed by Gram, genetic analysis revealed that Broussoflavonol F increased the abundance of beneficial bacteria such as Lactobacillus while decreasing the Firmicutes/Bacteroidetes ratio, a marker of obesity-related gut bacteria imbalance.
A 2026 mouse study demonstrated that the anti-obesity effects of Broussoflavonol F were completely dependent on gut microbiota, as the compound’s benefits were eliminated in antibiotic-treated mice but reproduced through fecal microbiota transplant from treated donors.
Research shows Broussoflavonol F improved glucose tolerance and reduced inflammation markers (TNF-α and IL-6) in obese mice while also enhancing gut barrier function, suggesting multiple pathways through which the compound addresses metabolic dysfunction.
The Quick Take
- What they studied: Whether a plant-based compound called Broussoflavonol F could help obese mice lose weight and improve their gut health
- Who participated: Laboratory mice that were made obese by eating a high-fat diet. The exact number of mice wasn’t specified in the abstract, but they were divided into treatment and control groups
- Key finding: After six weeks of treatment, mice given the compound lost significant weight, reduced their body fat, lowered cholesterol levels, and improved their ability to control blood sugar. Their gut bacteria also became more diverse and healthier
- What it means for you: This research is promising but still early-stage. It was done in mice, not humans, so we can’t yet say whether it will work the same way in people. If human studies confirm these results, this compound could eventually become a treatment option for obesity
The Research Details
Scientists took mice that were obese from eating a high-fat diet and gave some of them Broussoflavonol F for six weeks while others received no treatment. They measured changes in body weight, fat tissue, cholesterol levels, and blood sugar control. They also analyzed the mice’s gut bacteria using genetic sequencing to see which bacteria were present and in what amounts.
To prove that the gut bacteria were actually responsible for the weight loss, researchers did two additional experiments. First, they gave antibiotics to some mice to kill their gut bacteria, then gave them the compound, and it didn’t work anymore. Second, they transferred gut bacteria from treated mice into untreated mice, and those mice also lost weight. This proved the compound works by changing gut bacteria, not through some other mechanism.
The researchers measured inflammation markers in the blood and looked at genes in fat tissue to understand how the compound was working at the molecular level.
This research approach is important because it goes beyond just showing that something works, it proves why it works. By using antibiotics to eliminate gut bacteria and then using fecal transplants to restore them, the scientists proved that the gut microbiota is the key mechanism. This is much stronger evidence than simply showing weight loss, because it identifies the actual biological pathway involved
This study was published in a peer-reviewed scientific journal (Molecular Nutrition & Food Research), which means other experts reviewed it before publication. The research used multiple experimental approaches to confirm findings, which strengthens the conclusions. However, this was an animal study in mice, not humans, so results may not directly translate. The abstract doesn’t specify the exact number of mice used, which makes it harder to assess statistical power. More research in humans would be needed before this could become a medical treatment
What the Results Show
After six weeks of Broussoflavonol F treatment, obese mice showed significant improvements across multiple health markers. Body weight decreased noticeably, and the amount of fat tissue stored in their bodies was substantially reduced. Blood cholesterol levels (measured as total cholesterol, triglycerides, and LDL cholesterol) all dropped significantly compared to untreated mice.
The mice also showed improved glucose tolerance, meaning their bodies handled blood sugar better, an important marker of metabolic health. The compound appeared to work by turning down genes that control fat storage and fat production in two different types of fat tissue (inguinal and epididymal fat). Additionally, the compound reduced inflammation markers in the blood (TNF-α and IL-6), which are often elevated in obese individuals and contribute to health problems.
The most interesting finding involved gut bacteria. Genetic analysis showed that the compound increased the diversity of bacteria in the mice’s guts and increased beneficial bacteria like Lactobacillus. It also reduced the ratio of Firmicutes to Bacteroidetes bacteria, which is typically elevated in obesity and considered a sign of unhealthy gut bacteria balance.
The research showed that the compound improved gut barrier function, meaning the intestinal lining became healthier and more effective at controlling what passes through it. This is important because a leaky gut barrier can allow harmful substances to enter the bloodstream and trigger inflammation. The study also demonstrated that the anti-obesity effects were completely dependent on gut bacteria, when researchers eliminated the bacteria with antibiotics, the compound no longer worked. Conversely, when they transferred gut bacteria from treated mice to untreated mice, the untreated mice also experienced weight loss and metabolic improvements, proving the bacteria themselves were responsible for the benefits
This research builds on growing evidence that gut bacteria play a crucial role in obesity and metabolic health. Previous studies have shown that obese people have different gut bacteria composition than lean people, but this study goes further by demonstrating that changing the bacteria can actually reverse obesity-related problems. The finding that a plant compound can reshape gut bacteria aligns with other research showing that certain dietary components can influence microbial communities. This adds to the emerging field of using natural compounds to treat obesity through the gut microbiota rather than just restricting calories
This study was conducted entirely in mice, so we cannot assume the same results will occur in humans. Mouse metabolism differs from human metabolism in important ways. The abstract doesn’t specify how many mice were used, making it impossible to assess whether the sample size was large enough to draw reliable conclusions. We don’t know if the compound was tested at different doses or if the six-week timeframe is optimal. The study doesn’t tell us whether the weight loss would be maintained if treatment stopped or if it would continue indefinitely. Additionally, this research doesn’t address potential side effects or whether the compound might interact with medications. Human clinical trials would be necessary before this could be recommended as a treatment
The Bottom Line
Based on this animal research, we cannot yet recommend Broussoflavonol F as a treatment for human obesity. The evidence is promising but preliminary. If you’re interested in supporting gut health and weight management, current evidence-based approaches include eating fiber-rich foods, fermented foods with beneficial bacteria, reducing processed foods, and maintaining regular physical activity. These approaches have strong human evidence supporting them. Confidence level: This is early-stage research requiring human studies before clinical recommendations can be made
This research is most relevant to obesity researchers, pharmaceutical companies developing new treatments, and people with obesity who are interested in emerging therapeutic options. It’s less immediately relevant to the general public since it’s not yet applicable to humans. People with metabolic syndrome, type 2 diabetes, or obesity may eventually benefit if human trials confirm these findings. Healthcare providers treating obesity should be aware of this research direction but cannot yet incorporate it into clinical practice
In mice, significant changes appeared within six weeks. If this compound moves to human trials, it typically takes 5-10 years of research before a new treatment becomes available to the public. Even if human trials show promise, regulatory approval processes add additional time. Realistic expectation: This is a 5-15 year timeline before potential clinical availability, assuming successful human studies
Frequently Asked Questions
Can I take Broussoflavonol F to lose weight right now?
Not yet. This compound has only been tested in mice, not humans. Researchers must conduct human clinical trials to determine if it’s safe and effective for people before it could become available as a treatment. This process typically takes many years.
How does fixing gut bacteria help with weight loss?
Healthy gut bacteria help regulate metabolism, reduce inflammation, improve blood sugar control, and may influence appetite hormones. Obese people often have imbalanced gut bacteria that contributes to weight gain. Restoring beneficial bacteria like Lactobacillus can reverse these problems, as this study demonstrated in mice.
What can I do now to improve my gut bacteria for weight management?
Eat more fiber-rich foods (vegetables, whole grains, beans), include fermented foods (yogurt, kefir, sauerkraut, kimchi), reduce processed foods, and stay physically active. These evidence-based approaches support beneficial gut bacteria and are available to you today.
Why did researchers use mice instead of testing humans directly?
Animal studies are necessary first steps to understand how compounds work and to identify potential side effects before testing in humans. Mouse metabolism is similar enough to human metabolism to provide useful information, but different enough that human trials are still essential to confirm safety and effectiveness.
How long would it take for this to become a treatment for obesity?
If human trials confirm the mouse study results, it typically takes 5-15 years before regulatory approval and clinical availability. This includes multiple phases of human testing, safety monitoring, and regulatory review by agencies like the FDA.
Want to Apply This Research?
- Track daily fiber intake (target 25-30 grams) and fermented food consumption (servings of yogurt, kefir, sauerkraut, or kimchi), as these support beneficial gut bacteria similar to what the study showed. Monitor weekly weight and waist circumference to see if dietary changes supporting gut health correlate with changes in body composition
- Increase consumption of prebiotic foods (fiber sources like oats, beans, garlic, onions) and probiotic foods (fermented foods like yogurt and sauerkraut) to support gut bacteria diversity. The app could send reminders to include one fermented food and one high-fiber food daily, tracking compliance and correlating with weight changes over 6-8 weeks
- Establish a baseline of current weight, waist circumference, and energy levels. Track these weekly while implementing dietary changes to support gut health. After 6-8 weeks, compare results to baseline. Also track digestive health (bloating, regularity, energy) as indirect indicators of gut microbiota changes. Note any changes in cravings or appetite, which may shift as gut bacteria composition changes
This article discusses early-stage research conducted in mice and should not be interpreted as medical advice or a recommendation for human use. Broussoflavonol F has not been tested in humans and is not currently available as a treatment. Anyone with obesity or metabolic concerns should consult with a healthcare provider about evidence-based treatment options. This research is promising but preliminary; human clinical trials would be necessary before any therapeutic claims could be made. Do not attempt to self-treat obesity based on this animal research. Always seek professional medical guidance for weight management and metabolic health.
This research translation is published by Gram Research, the science division of Gram, an AI-powered nutrition tracking app.
